Proteomics International at American Diabetes Association (ADA) conference 2019 – June 7–11 – San Francisco, CA
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) was invited to feature on the American Diabetes Association (ADA) TV News Network as a key opinion leader (KOL) on diabetic kidney disease diagnostics, which includes an update on PromarkerD, during the ADA 79th Scientific Sessions conference (San Francisco, June 7-11, 2019).
Proteomics International Managing Director Dr Richard Lipscombe outlines the impact PromarkerD will have saving lives and healthcare costs, and the global roll-out plans for PromarkerD in the exclusive interview to be broadcast at the industry’s leading conference.